Similar articles

• [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].

  Mertz DP. Mertz DP. Fortschr Med. 1979 Apr 19;97(15):695-6, 698. Fortschr Med. 1979. PMID: 456970 German.
• [Indications for surgical treatment and medical treatment of atherosclerosis].

  Paredero Del Bosque Martin V. Paredero Del Bosque Martin V. Minerva Med. 1980 Oct 20;71(40):2963-7. Minerva Med. 1980. PMID: 7454082 Italian. No abstract available.
• Treatment of hyperlipidemia.

  Levy RI, Morganroth J, Rifkind BM. Levy RI, et al. N Engl J Med. 1974 Jun 6;290(23):1295-301. doi: 10.1056/NEJM197406062902306. N Engl J Med. 1974. PMID: 4363888 Review. No abstract available.
• Drug therapy of hyperlipoproteinemia.

  Levy RI. Levy RI. JAMA. 1976 May 24;235(21):2334-6. JAMA. 1976. PMID: 946632 No abstract available.
• [Therapeutic orientation in the hyperlipidemias].

  Forti N, Diament J, Giannini SD. Forti N, et al. Arq Bras Cardiol. 1979 Sep;33(3):207-15. Arq Bras Cardiol. 1979. PMID: 396911 Review. Portuguese. No abstract available.